Concepedia

Roman L. Bogorad

RL

38

Publications

7.7K

Citations

29

H-Index

2003

Active since

Affiliations

Massachusetts Institute of Technology(Current)

Skolkovo Institute of Science and Technology

Lomonosov Moscow State University

Alnylam Pharmaceuticals (United States)

Harvard University

Roman L. Bogorad is an author at Massachusetts Institute of Technology specializing in medicine, cell biology, and molecular biology.

Top concepts

MedicineCell BiologyMolecular BiologyEngineeringSignal TransductionCell SignalingLiverGenome EditingGene ExpressionLiver Physiology

Publications per year

2003–2020

38

Publications

38

Integrative genomics identifies MCU as an essential component of the mitochondrial calcium uniporter

Joshua M. Baughman, Fabiana Perocchi, Hany S. Girgis et al. · Nature · 2011 · 1.9K citations · Full text

Molecular Physiology, Mitochondrial Function, Natural Sciences +9

Therapeutic genome editing by combined viral and non-viral delivery of CRISPR system components in vivo

Hao Yin, Chun‐Qing Song, J. Robert Dorkin et al. · Nature Biotechnology · 2016 · 862 citations · Full text

Engineering, Genome Surgery, In Vivo Gene Therapy +13

In vivo endothelial siRNA delivery using polymeric nanoparticles with low molecular weight

James E. Dahlman, Carmen Barnes, Omar F. Khan et al. · Nature Nanotechnology · 2014 · 567 citations · Full text

Nanoparticles, Nanomedicine, Cell-based Drug Delivery +7

Cholangiocytes act as facultative liver stem cells during impaired hepatocyte regeneration

Alexander Raven, Wei‐Yu Lu, Tak Yung Man et al. · Nature · 2017 · 518 citations · Full text

Cholangiocytes Act, Organ Development, Cholangiopathies +17

Structure-guided chemical modification of guide RNA enables potent non-viral in vivo genome editing

Hao Yin, Chun‐Qing Song, Sneha Suresh et al. · Nature Biotechnology · 2017 · 482 citations · Full text

Engineering, Genome Surgery, In Vivo Gene Therapy +10

Rows per page

1–5 of 38